Physician profile
Chandra Ojha
NPI 1831352145
$4,766.86
in general payments reported to CMS, 2019-2025
24 companies · $551 in 2025
The $551 reported for 2025 was less than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,093 · 2020: $487 · 2021: $327 · 2022: $710 · 2023: $243 · 2024: $358 · 2025: $551.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,151.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,150.83 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medical Device Business Services, INC. | $1,122.08 | 2019 | |
| Boston Scientific Corporation | $918.63 | 2019-2024 | Ffr Link |
| Shockwave Medical, INC | $503.63 | 2021-2022 | |
| Abiomed | $390.95 | 2021-2025 | Impella |
| Amgen INC. | $365.12 | 2023-2025 | Repatha, Repatha |
| Medtronic, INC. | $239.31 | 2021-2025 | Onyx Frontier, Endurant Iis, Symplicity G3 |
| Edwards Lifesciences Corporation | $172.99 | 2020-2024 | Sapien 3 Ultra Resilia |
| Penumbra, INC. | $172.09 | 2019 | |
| Philips North America LLC | $170.84 | 2022 | |
| Novartis Pharmaceuticals Corporation | $168.55 | 2021-2025 | |
| Terumo Medical Corporation | $129.98 | 2020 | |
| Medtronic Vascular, INC. | $65.12 | 2020 | |
| Abbott Laboratories | $51.79 | 2019 | |
| Teleflex LLC | $50.34 | 2023-2025 | Langston, Manta |
| Heartflow, INC. | $39.71 | 2022 |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Inari Medical, INC. | $36.49 | 2025 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Impulse Dynamics (USA) INC. | $30.72 | 2023 | Optimizer |
| Seapearl East, INC | $25.87 | 2024 | |
| Cardiva Medical, INC. | $24.22 | 2023 | Cardiva Vascade Mvp Vvcs 6-12f |
| Cvrx, INC. | $23.41 | 2023 | Barostim Neo System |
| W. L. Gore & Associates, INC. | $18.20 | 2021 | |
| Pfizer INC. | $17.89 | 2025 | |
| Kiniksa Pharmaceuticals International, Plc | $15.40 | 2024 | Arcalyst |
| E.R. Squibb & Sons, L.L.C. | $13.53 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Chandra Ojha listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.